Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Intradialytic Hypotension: full-pipeline trial registry
3 of 4 indexed Intradialytic Hypotension trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Intradialytic Hypotension: 4 US clinical trials tracked, 3 recruiting.
Intradialytic Hypotension is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Chelsea Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition intradialytic-hypotension
OPEN 3 | RECR 75% | LATE 1 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Intradialytic Hypotension lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Intradialytic Hypotension on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Intradialytic Hypotension is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Trial of Variable Dialysate Bicarbonate
Brigham and Women's Hospital
NCT05814146
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
VA Office of Research and Development
NCT04163614
Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor
Vanderbilt University Medical Center
NCT05834777
Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension
Chelsea Therapeutics
NCT00657046
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Intradialytic Hypotension records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Intradialytic Hypotension trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Intradialytic Hypotension page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Intradialytic Hypotension trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Chelsea Therapeutics sponsors the most Intradialytic Hypotension trials on record, review their full trial history before evaluating a specific study. See Chelsea Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Intradialytic Hypotension condition card totals 4 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.